Last updated : 24/04/2026 - 17h35 (last close)

Last close data

Top performers:

DASSAULT SYSTEMES

STMICROELECTRONICS

Worst performers:

ESSILORLUXOTTICA

🏠 Home ➤ Stock news

GENFIT Receives $20 Million from Ipsen Following Iqirvo's Sales Success

GENFIT will receive a milestone payment of $20 million following the surpassing of $200 million in net sales for Iqirvo® in its first full year of commercialization.

Published on Feb 12, 2026 at 17:48

GENFIT Receives $20 Million from Ipsen Following Iqirvo's Sales Success

8.18 € -0.24 %

GENFIT is set to receive a milestone payment of $20 million. This payment is contingent upon exceeding the threshold of $200 million in net sales for Iqirvo® during its first complete year of commercialization.

Free · Every morning

Technical market signals, before the opening bell.

Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.

✓ Before 9 AM every morning ✓ Euronext data ✓ AI-powered analysis

Indicative data. No investment advice. Unsubscribe at any time.

Related

🏢 Other stocks — Santé

🗞️ MedInCell Stock Tests Key Technical Threshold Despite +60% Yearly Gain 🗞️ Clariane Shares Surge Over 5%, Crossing 4 Euros in Defiance of CAC 40 🗞️ BioMérieux Shares Hit Seven-Year Low After Disappointing Quarter 🗞️ Clariane: Organic Growth of 4.9% in the First Quarter

Sector Santé · Biotechnologies · Pharmacie › Biotechnologie

Assurance vie

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Also read

📈 View GENFIT stock page

GENFIT: Revenue of €65M in 2025, but Net Loss Widens to €86M Published on Apr 02, 2026

GENFIT: FDA Grants Key Designation to Its Candidate for Cirrhosis Published on Mar 10, 2026

🏢 All news on GENFIT

📈 Analyst Ratings

Price Targets: Changes for STMicroelectronics, Capgemini, Vinci, and Others Published on Apr 24, 2026

FDJ United Shares Hold Steady at Midday Despite Two Analyst Downgrades in 48 Hours Published on Apr 24, 2026

Air Liquide Shares Reach New Historic High, Bucking the Trend of the CAC 40 Published on Apr 24, 2026

Eutelsat Stock in Overbought Territory After +28% in Three Months: Can the €2.94 Resistance Give Way? Published on Apr 24, 2026

Advertisement

Every morning

Technical market signals,
before the opening bell.

CAC 40 · SBF 120 · Signals · Analysts

🤖

Today's edition — pre-market

CAC 40

7 702

-0,87%

SBF 120

5 827

-0,87%

📈 Bullish signals

+5,2%

+1,8%

+0,9%

📉 Bearish signals

-14%

-5,7%

🔄 Analyst opinions

▲ 35 €

▼ 80 €

Sign up to see everything →

Before 9 AM every morning

Euronext data

AI-powered analysis

Indicative data. No investment advice. Unsubscribe at any time.

The content of this website does not constitute investment advice or recommendations.
Investing in financial markets or any investment product involves risk. You should ensure you can afford to lose all or part of your capital.
© 2012 - 2026 - Idéal investisseur